相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Aptamers as targeted therapeutics: current potential and challenges
Jiehua Zhou et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms
Teresa M. Seccia et al.
JOURNAL OF HYPERTENSION (2017)
Receptor for advanced glycation endproducts and progressive kidney disease
Kei Fukami et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2015)
Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease
Sho-ichi Yamagishi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Recent Topics on Podocytes and Aldosterone
Miki Nagase
JOURNAL OF RENAL NUTRITION (2015)
Agonistic aptamer to the insulin receptor leads to biased signaling and functional selectivity through allosteric modulation
Na-Oh Yunn et al.
NUCLEIC ACIDS RESEARCH (2015)
Role of Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Cancer Risk
Sho-ichi Yamagishi et al.
REJUVENATION RESEARCH (2015)
Urinary Podocyte Microparticles Identify Prealbuminuric Diabetic Glomerular Injury
Dylan Burger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Asymmetric dimethylarginine accumulates in the kidney during ischemia/reperfusion injury
Yosuke Nakayama et al.
KIDNEY INTERNATIONAL (2014)
The effect of peroxynitrite decomposition catalyst MnTBAP on aldehyde dehydrogenase-2 nitration by organic nitrates: Role in nitrate tolerance
Vincenzo Mollace et al.
PHARMACOLOGICAL RESEARCH (2014)
Anti-albuminuric effect of the aldosterone blocker eplerenone in non-diabetic hypertensive patients with albuminuria: a double-blind, randomised, placebo-controlled trial
Katsuyuki Ando et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
DNA Aptamer Raised Against AGEs Blocks the Progression of Experimental Diabetic Nephropathy
Yusuke Kaida et al.
DIABETES (2013)
PEDF inhibits AGE-induced podocyte apoptosis via PPAR-gamma activation
Yuji Ishibashi et al.
MICROVASCULAR RESEARCH (2013)
Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease
Miki Nagase et al.
NATURE REVIEWS NEPHROLOGY (2013)
Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice
Yoshimi Takamiya et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
The alternative crosstalk between RAGE and nitrative thioredoxin inactivation during diabetic myocardial ischemia-reperfusion injury
Yi Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2012)
Angiotensinergic Signaling in the Brain Mediates Metabolic Effects of Deoxycorticosterone (DOCA)-Salt in C57 Mice
Justin L. Grobe et al.
HYPERTENSION (2011)
Activation of Receptor for Advanced Glycation End Products Induces Osteogenic Differentiation of Vascular Smooth Muscle Cells
Toshihiro Suga et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2011)
Rac1 GTPase in rodent kidneys is essential for salt-sensitive hypertension via a mineralocorticoid receptor-dependent pathway
Shigeru Shibata et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Nifedipine, a calcium channel blocker, inhibits inflammatory and fibrogenic gene expressions in advanced glycation end product (AGE)-exposed fibroblasts via mineralocorticoid receptor antagonistic activity
Takanori Matsui et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Podocyte Loss in Human Hypertensive Nephrosclerosis
Gang Wang et al.
AMERICAN JOURNAL OF HYPERTENSION (2009)
Pure MnTBAP selectively scavenges peroxynitrite over superoxide: Comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan-induced pleurisy
Ines Batinic-Haberle et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes
Aino Soro-Paavonen et al.
DIABETES (2008)
Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor - Role of oxidative stress
Miki Nagase et al.
HYPERTENSION (2007)
In vitro selection of DNA aptamers that block toxic effects of AGE on cultured retinal pericytes
Yuichiro Higashimoto et al.
MICROVASCULAR RESEARCH (2007)
Nox1-based NADPH oxidase-derived superoxide is required for VSMC activation by advanced glycation end-products
Alejandra San Martin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
The spectrum of podocytopathies: A unifying view of glomerular diseases
R. C. Wiggins
KIDNEY INTERNATIONAL (2007)
Functional aptamers and aptazymes in biotechnology, diagnostics, and therapy
Michael Famulok et al.
CHEMICAL REVIEWS (2007)
Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease
S. Bianchi et al.
KIDNEY INTERNATIONAL (2006)
Advanced glycation end products - Sparking the development of diabetic vascular injury
Alison Goldin et al.
CIRCULATION (2006)
The renin-angiotensin system in glomerular podocytes: Mediator of glomerulosclerosis and link to hypertensive nephropathy
Raghu V. Durvasula et al.
CURRENT HYPERTENSION REPORTS (2006)
Effects of valsartan on the progression of chronic renal insufficiency in patients with nondiabetic renal diseases
T Ishimitsu et al.
HYPERTENSION RESEARCH (2005)
Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice
A Flyvbjerg et al.
DIABETES (2004)
Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response
B Liliensiek et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Glucose, glycation, and RAGE: Implications for amplification of cellular dysfunction in diabetic nephropathy
T Wendt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties
S Yamagishi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Characterization of a novel EGFP reporter mouse to monitor Cre recombination as demonstrated by a Tie2 Cre mouse line
R Constien et al.
GENESIS (2001)
Aldosterone as a mediator of progressive renal disease: Pathogenetic and clinical implications
M Epstein
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
T Nishikawa et al.
NATURE (2000)